Literature DB >> 8876977

Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS-1.

K S Saini1, C Thompson, C M Winterford, N I Walker, D P Cameron.   

Abstract

The ability of beta cells to endure assaults by various environmental agents, including toxins and viruses, may be relevant to the development of diabetes. We have examined the mode of cell death caused by streptozotocin (STZ) in a murine pancreatic beta cell line, INS-1. Apoptosis was identified by detection of initial endonuclease-mediated DNA strand breaks by DNA gel electrophoresis. Apoptosis and necrosis were distinguished morphologically by light and electron microscopy. Higher rates of apoptosis, as compared to necrosis, were observed when cells were exposed to 15 mM STZ for 1 hr followed by a 24 hrs recovery period. Higher doses of STZ (30 mM) caused the cells to undergo necrosis (22%) as well as apoptosis (17%). These results suggest that the cytotoxic effect of STZ, at low doses, on beta cells involves the activation of the apoptotic pathway, whereas, at high doses, the mode of beta cell death is predominantly necrosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8876977     DOI: 10.1080/15216549600201422

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  24 in total

1.  A rat model of diabetic artery calcification.

Authors:  X Ren; Qin Wei; H Shao; Z Sun; N Liu
Journal:  J Endocrinol Invest       Date:  2011-07-12       Impact factor: 4.256

2.  Transgenic expression of Hsc70 in pancreatic islets enhances autoimmune diabetes in response to beta cell damage.

Authors:  Masih-ul Alam; Julie A Harken; Anna-Maria Knorn; Alisha R Elford; Kip Wigmore; Pamela S Ohashi; Douglas G Millar
Journal:  J Immunol       Date:  2009-10-07       Impact factor: 5.422

3.  Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus.

Authors:  Nicole Liadis; Kiichi Murakami; Mohamed Eweida; Alisha R Elford; Laura Sheu; Herbert Y Gaisano; Razqallah Hakem; Pamela S Ohashi; Minna Woo
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

4.  Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes.

Authors:  Tracey M Gloster; David J Vocadlo
Journal:  Curr Signal Transduct Ther       Date:  2010-01

5.  Pseudoislet formation enhances gene expression, insulin secretion and cytoprotective mechanisms of clonal human insulin-secreting 1.1B4 cells.

Authors:  Alastair D Green; Srividya Vasu; Neville H McClenaghan; Peter R Flatt
Journal:  Pflugers Arch       Date:  2015-01-06       Impact factor: 3.657

6.  The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase.

Authors:  R J Konrad; I Mikolaenko; J F Tolar; K Liu; J E Kudlow
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

7.  Streptozotocin-resistant BRIN-BD11 cells possess wide spectrum of toxin tolerance and enhanced insulin-secretory capacity.

Authors:  Hui-Kang Liu; Jane T McCluskey; Neville H McClenghan; Peter R Flatt
Journal:  Endocrine       Date:  2007-09-29       Impact factor: 3.633

8.  Heat shock protein 27 overexpression mitigates cytokine-induced islet apoptosis and streptozotocin-induced diabetes.

Authors:  Tiane Dai; Mina Patel-Chamberlin; Rama Natarajan; Ivan Todorov; Jun Ma; Janine LaPage; Lynetta Phillips; Cynthia C Nast; Diana Becerra; Peter Chuang; Lili Tong; Jacqueline de Belleroche; Dominic J Wells; Ying Wang; Sharon G Adler
Journal:  Endocrinology       Date:  2009-03-26       Impact factor: 4.736

9.  Activated FoxM1 attenuates streptozotocin-mediated β-cell death.

Authors:  Maria L Golson; Matthew F Maulis; Jennifer C Dunn; Greg Poffenberger; Jonathan Schug; Klaus H Kaestner; Maureen A Gannon
Journal:  Mol Endocrinol       Date:  2014-07-29

10.  Streptozotocin-induced cytotoxicity, oxidative stress and mitochondrial dysfunction in human hepatoma HepG2 cells.

Authors:  Haider Raza; Annie John
Journal:  Int J Mol Sci       Date:  2012-05-11       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.